Clinical trial
Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low…
NCT00016783 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00016783 |
|---|---|
| Title | Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV |
| Official title | Intensification of HIV-Specific CD4 and CD8 Activity by Cycling Highly Active Antiretroviral Therapy (HAART) in Pediatric/Adolescent Patients With Less Than 50 HIV RNA Copies/ml |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections |
| Enrollment | 39 |
| Completion | Oct 1, 2006 |
| First posted | Aug 31, 2001 |
| Last update posted | Oct 7, 2013 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: